PILOT
831175
XINGANJIANG
873167
Beijing Highlander Digital Technology
300065
4
Xiamen Hongxin Electronics Technology Group Inc.
300657
5
Shijihengtong Technology
301428
US Stock MarketDetailed Quotes
SPRO Spero Therapeutics
- 0.815
- -0.002-0.21%
Close Feb 14 16:00 ET
- 0.830
- +0.015+1.84%
Post 20:01 ET
44.43MMarket Cap10.19P/E (TTM)
0.815High0.800Low90.54KVolume0.808Open0.817Pre Close73.30KTurnover0.22%Turnover Ratio1.90P/E (Static)54.52MShares1.89052wk High0.68P/B33.09MFloat Cap0.74052wk Low--Dividend TTM40.60MShs Float23.639Historical High--Div YieldTTM1.80%Amplitude0.680Historical Low0.809Avg Price1Lot Size
Spero Therapeutics News
Spero Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Keutzer Timothy
Spero Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Rajavelu Esther
Spero Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Shukla Sath
Spero Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Mahadevia Ankit
Spero Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Anson Funds Management LP(6.9%),Anson Management GP LLC(6.9%), etc.
Spero Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Rajavelu Esther
Spero Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Mahadevia Ankit
Spero Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Keutzer Timothy
Spero Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Shukla Sath
Spero Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Shukla Sath
Spero Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Deshpande Milind
Spero Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Jackson Scott Thomas
Spero Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Pottage John C Jr
Spero Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director THOMAS FRANK E
Spero Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Smith Cynthia
Spero Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director VINK PATRICK V.J.J.
Spero Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Tregoning Kathleen
Spero Therapeutics | SC 13G: Statement of acquisition of beneficial ownership by individuals-Anson Funds Management LP(8.1%),Anson Management GP LLC(8.1%), etc.
Spero Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Keutzer Timothy
Spero Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Mahadevia Ankit
Trending Stocks
Discussing
Many institutions are bullish! What's ahead for Chinese stocks in 2025?
Recently, institutions such as Goldman Sachs, Morgan Stanley, and Appaloosa LP have spoken positively about Chinese assets. 🎙️Discussion: 1
Popular on moomoo
Feb 13 17:34
China's asset revaluation sparks debate: What are mooers buying?